These findings are directly relevant to retatrutide because the molecule shares structural similarities with the GLP-1 agonists tested
Similarly, combining semaglutide with tirzepatide at the same time is not recommended due to overlapping mechanisms
(Human) FDA prescribing information for the specific GLP-1 medication (for example Ozempic, Wegovy, Mounjaro, or Zepbound)
The model: stack indications, expand labels, and reposition semaglutide and tirzepatide for broader use heart failure, CKD, NASH, addiction
Over a 12-week period, the participants were randomized to receive dulaglutide 1.5 mg, placebo, or once-weekly subcutaneous injections of LY3437943
It acts on three receptors that regulate appetite, blood sugar, and fat metabolism